Viela Bio, Inc. SEC Filings

Filed On	Filing
25 Mar 2021	15-12B
17 Mar 2021	SC 13D/A
16 Mar 2021	Form 4: Cao Yanling, Director Returned 8,322,353 shares to the issuer ($441M)
16 Mar 2021	Form 4: Rivers Tyrell, Director
16 Mar 2021	Form 4: Astrazeneca Plc, 10% owner and 1 other Disposed of 14,650,334 shares (Tender Offer) ($776M)
15 Mar 2021	Form 4: Wicki Andreas, Director Returned 1,750,000 shares to the issuer ($92.8M)
15 Mar 2021	Form 4: Hu Edward, Director Returned 4,161,177 shares to the issuer ($221M) · Disposed of 33,568 Stock Option (right to buy) (Disposition to Issuer)
15 Mar 2021	Form 4: Boundless Meadow Ltd, 10% owner and 8 others Disposed of 8,622,353 shares (Tender Offer) ($457M)
15 Mar 2021	Form 4: Chan Mitchell, Chief Financial Officer Returned 37,500 shares to the issuer ($1.99M) · Disposed of 160,556 Stock Option (right to buy) (Disposition to Issuer)
15 Mar 2021	Form 4: Drappa Jorn, Chief Medical Officer Returned 202,661 shares to the issuer ($10.7M) · Disposed of 300,842 Stock Option (right to buy) (Disposition to Issuer)
15 Mar 2021	Form 4: Kastenmayer James Paul, General Counsel Disposed of 50,000 Stock Option (right to buy) (Disposition to Issuer)
15 Mar 2021	S-8 POS
15 Mar 2021	Form 4: Nolet Chris, Director Disposed of 33,568 Stock Option (right to buy) (Disposition to Issuer)
15 Mar 2021	Form 4: Jacques Rachelle Suzanne, Director Disposed of 22,074 Stock Option (right to buy) (Disposition to Issuer)
15 Mar 2021	Form 4: Ragatz William, Senior VP, Head of Commercial Returned 16,250 shares to the issuer ($861K) · Disposed of 112,298 Stock Option (right to buy) (Disposition to Issuer)
15 Mar 2021	Form 4: Yao Zhengbin, Director Returned 470,219 shares to the issuer ($24.9M) · Disposed of 617,432 Stock Option (right to buy) (Disposition to Issuer)
15 Mar 2021	S-8 POS
15 Mar 2021	POSASR
15 Mar 2021	SC 14D9/A
15 Mar 2021	25-NSE

Comments